USD10
TLPH Shares
About TalpheraTalphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
USD10
TLPH Shares
About TalpheraTalphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$66.43M
OPEN PRICE
$1.35
LOW (1Y)
$0.3862
HIGH (1Y)
$1.57
LOW (24H)
$1.28
HIGH (24H)
$1.41
VOLUME (24H)
$197.35K
177.74%
Price history
Time | Price | Change |
|---|---|---|
Today | $1.35 | |
1 Day | $1.29 | |
1 Week | $1.34 | |
1 Month | $1.01 | |
1 Year | Not enough data | Not enough data |
Past performance is not a reliable indicator of future results.
Discover more
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.
